![]() | ![]() |
Formats:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright : © 2007 De Renzis et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Unmasking Activation of the Zygotic Genome Using Chromosomal Deletions in the Drosophila Embryo 1 Howard Hughes Medical Institute, Department of Molecular Biology, Princeton University, New Jersey, United States of America 2 Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, New Jersey, United States of America Tom Kornberg, Academic Editor University of California San Francisco, United States of America * To whom correspondence should be addressed. E-mail: stefanod/at/Princeton.edu (SDR); Email: efw/at/Princeton.edu (EFW) Received October 18, 2006; Accepted February 28, 2007. This article has been corrected. See PLoS Biol. 2007 August 14; 5(8): e213. This article has been corrected. See PLoS Biol. 2007 July 17; 5(7): e195. This article has been cited by other articles in PMC.Abstract During the maternal-to-zygotic transition, a developing embryo integrates post-transcriptional regulation of maternal mRNAs with transcriptional activation of its own genome. By combining chromosomal ablation in Drosophila with microarray analysis, we characterized the basis of this integration. We show that the expression profile for at least one third of zygotically active genes is coupled to the concomitant degradation of the corresponding maternal mRNAs. The embryo uses transcription and degradation to generate localized patterns of expression, and zygotic transcription to degrade distinct classes of maternal transcripts. Although degradation does not appear to involve a simple regulatory code, the activation of the zygotic genome starts from intronless genes sharing a common cis-element. This cis-element interacts with a single protein, the Bicoid stability factor, and acts as a potent enhancer capable of timing the activity of an exogenous transactivator. We propose that this regulatory mode links morphogen gradients with temporal regulation during the maternal-to-zygotic transition. Author Summary Embryonic development is controlled by a complex interaction between maternal and zygotic activities. Maternal messenger RNAs and proteins are deposited in the unfertilized egg during oogenesis; after fertilization, the activation of the zygotic genome is accompanied by the degradation of a fraction of maternally supplied transcripts. This switch from maternal to zygotic control of development is characterized by a dramatic remodeling of gene expression, and represents a universal regulatory point during animal development. Because it is not usually possible to identify which genomes are contributing to these transcriptional changes, we have used chromosomal ablation to determine maternal versus zygotic contribution for each mRNA detectable on microarray in the Drosophila blastoderm. This has allowed us to distinguish transcriptional and post-transcriptional modes of regulation and to identify common cis-regulatory elements associated with different classes of transcripts. Our analysis revealed that although mRNA degradation does not involve a simple regulatory code, the activation of the zygotic genome is based on a simple mechanism, which links morphogen gradients with temporal regulation. It will be interesting to address whether similar mechanisms also operate in other animals. Introduction Embryonic development is controlled by a complex interaction between maternal and zygotic activities. Although maternal transcripts and proteins are deposited in the egg during oogenesis, the activation of the zygotic genome starts at different stages in different animals and is concomitant with the degradation of a fraction of maternally supplied transcripts [1–3]. Thus, during the maternal-to-zygotic transition (MZT), the embryo undergoes an extensive remodeling of gene expression and must integrate post-transcriptional regulatory mechanisms, which are the only ones operating during the previous maternal stages, with transcriptional regulation of its own genome. How this is achieved is poorly understood. The concomitant degradation of maternal transcripts and activation of zygotic transcription has made it difficult in any animal to interpret changes in gene expression [4–6]. Whereas an increase in gene expression levels can be interpreted as a sign of zygotic transcription, a decrease or absence of change is also consistent with zygotic gene activation if it is accompanied by maternal mRNA degradation. One way to test whether a particular RNA is supplied maternally or zygotically is to compare its levels in embryos that have or do not have the corresponding DNA template. Under these conditions, differences in expression level indicate the relative maternal and zygotic contribution. Drosophila melanogaster offers the unique opportunity to perform such an experiment for the entire genome, as it is possible to use chromosomal rearrangements to produce embryos that lack specific arms or even entire chromosomes [7,8]. Such embryos develop normally until cycle 14 and then show defects characteristic of the chromosomal region deleted. The results of such experiments suggest that the Drosophila embryo develops under the control of maternally provided proteins until nuclear division 13. This stage, usually referred to as the mid-blastula transition (MBT), defines the point from which development comes to be controlled by the zygote's own genome [1]. The first morphological signs of the zygotic genome appear with the cellularization of the cortically migrating nuclei and the beginning of gastrulation. From a transcriptional point of view, the zygotic genome is silent until nuclear cycle 9–10 [9]. In the germline, this quiescence is maintained until later stages of development, arguing for specific regulation between the soma and the germline [10]. The molecular mechanisms linking the nuclear cycles to the activation of transcription are unknown and may involve the chromosomal squelching of negative regulators of transcription, as has been proposed for the Xenopus embryo [3]. Chromatin-based mechanisms may also play a role. In the mouse embryo, for example, at least one cycle of DNA replication is required to change the methylation state of the chromatin to a transcriptionally competent conformation [11]. However, in none of these organisms have the molecular players actually regulating activation of the zygotic genome been identified. Because such regulators must be maternally provided, they are not easily identifiable in genetic screens. On the other hand, the recent technological advances in genomics and bioinformatics may offer alternative strategies for elucidating this mechanism, especially if the identification of cis-regulatory elements can be coupled to a biochemical characterization of the factors that bind to them. Here we took advantage of the phenotype generated by the removal of specific genes acting during cellularization to identify embryos lacking defined chromosomal arms, and analyzed their expression profiles using microarrays. Because this strategy allows discrimination between transcriptional and post-transcriptional regulation of gene expression, we describe here the first complete analysis of the MZT during animal development. Results Time-Course Analysis Earlier attempts to identify zygotically active genes in Drosophila relied on comparing mRNA levels at cycle 14 with those from unfertilized eggs or early 0–1-h-old embryos [12]. Although zygotic transcription begins already at earlier nuclear cycles (9–10), we also started our analysis by focusing on cycle 14 because this stage represents the earliest time point at which the mutant phenotypes associated with the deletion of each specific chromosome can be recognized. The time-course characterization of earlier time points will be presented in the section describing the activation of the zygotic genome. The temporal resolution of our measurements is at 1-h intervals covering the first 3 h of embryogenesis: (1) unfertilized eggs, (2) 0–1 h (cycles 1 to 10), (3) 1–2 h (cycles 10 to 13), and (4) 2–3 h (cycle 14). Figure 1
Transcripts expressed at the same level in both collections lie on the diagonal (Figure 1 Identification of 2L Zygotic Genes The left arm of the second chromosome represents approximately 20% of the entire genome and is predicted to contain approximately 2,500 open reading frames (BDGP4 annotation; Berkeley Drosophila Genome Project, http://www.fruitfly.org/). We compared mRNAs from embryos that lack the left arm of the second chromosome with similarly staged wild-type embryos. Such 2L− embryos can be recognized by their distinctive halo of lipid-rich cortical cytoplasm during cellularization [13], at the precise moment when major zygotic transcription begins. Figure 1 Most mRNAs have similar levels in both collections, and lie on a diagonal (Figure 1 As we decrease the fold-change cut-off, the number of genes that deviate from the diagonal increases. A 2-fold cut-off identifies 378 genes on 2L whose levels depend on the presence of that chromosomal arm in the embryos. A 2-fold difference signifies that at least 50% of the total number of transcripts for each of these genes, present at cycle 14, are derived from zygotic rather than maternal transcription. The observation that even at this cut-off, approximately 60% of down-regulated genes are located on 2L strongly validates this procedure. Indeed, if the observed changes were due to random fluctuations of mRNA levels, such changes would be distributed over the entire genome, and 20% of them would be located on 2L. It should be noted that, in principle, the down-regulated transcripts might also include maternal mRNAs whose stability is regulated by zygotic transcription. However, the enrichment on 2L suggests that this applies to a very small fraction of genes. We therefore classify all down-regulated transcripts (on the deleted arm) as zygotic. The remaining 631 genes that are located on 2L and detected in cycle 14 embryos are not dependent on the presence of the left arm of the second chromosome in the embryo, and must therefore be supplied by maternal transcription. At the 2-fold cut-off, a second class of affected mRNAs appears. These mRNAs are expressed at a higher or lower level than the wild-type controls, and they mapped to other regions of the genome. We interpret these mRNAs as gene products whose levels depend indirectly on the left arm of the second chromosome. We therefore name these genes “secondary targets” of 2L removal. They may be targets of transcription factors encoded on 2L whose expression at cycle 14 depends on the presence of that arm. Alternatively, they might be post-transcriptionally regulated maternal transcripts whose stability or degradation depends on zygotic transcription. In order to discriminate between these mechanisms, we screened the entire genome and determined the maternal and zygotic contribution for each individual gene. Whole-Genome Identification of Zygotic Genes and Secondary Targets Using additional chromosomal rearrangements, we extended the analysis described in detail above for 2L to the rest of the genome, analyzing mRNA populations present in embryos deficient for the X chromosome, the entire second chromosome, or the entire third chromosome. In most cases, hybridizations were performed in quadruplicate using different batches of embryos. Mutant embryos were recognized under a compound microscope based on their specific abnormalities associated with defects in nuclear morphology, in actin-myosin dynamics, and organelle transport: nullo (chromosome X) [14], halo (Chromosome 2) [13], and bottleneck (Chromosome 3) [15]. These three phenotypes appear synchronously as the embryo enters cycle 14, thus allowing a precise staging protocol (Figure 2
A 3-fold cut-off identifies all mRNAs that are at least 67% supplied by zygotic transcription at cycle 14. Combining the data from all four manipulations, we estimate that such zygotically active genes represent about 18% of the genes detectable at cycle 14, i.e., 1,158 genes distributed on all four chromosomes (Table S1). The remaining mRNA species appear to be supplied predominantly by maternal transcription. When looking at the entire dataset, zygotically active genes appear to be uniformly distributed throughout the genome. Each chromosomal manipulation also identified apparent secondary targets that mapped to other chromosomes. Similar to the results obtained from the 2L− experiments, levels of such mRNAs deviated at most 2- to 3-fold in either the positive or the negative direction from wild-type (WT) mRNAs. To test whether these genes were in fact transcriptional targets of genes on the removed chromosome, we asked whether third chromosomal or X chromosomal genes identified in the 2L chromosomal screen as secondary targets behaved as primary targets when the third chromosome or X was removed. This was true for 62% of down-regulated and 29% of up-regulated genes. Our four experiments identified a total number of 778 secondary targets of which only 28% are zygotic (Table S2). The remaining 72% (563) are mostly maternally supplied. We conclude from these observations that the expression level of most zygotically active genes was not influenced by other loci, and changed significantly only when the chromosome encoding them was removed. Maternal Transcripts and Degradation The identification of 563 non-zygotic mRNAs (Table S3) whose level changed in response to the removal of a specific chromosome must represent post-transcriptional regulation of maternal transcripts. The stability or degradation of these transcripts may be regulated by transcription of certain factors (coding for RNA-binding proteins or regulatory RNAs) on the chromosomes that are removed. In agreement with this interpretation is the observation that ablation of each chromosome or chromosomal arm results in the misregulation of distinct targets. Thus, transcription at multiple loci regulates the stability of distinct maternal transcripts. For example, the degradation of String and Twine, two cell cycle regulators involved in timing the MZT [16], is regulated by zygotic transcription on the X and second chromosomes, respectively (Table S2). Next, we characterized the relative contribution of maternal transcripts to the total cycle 14 expression level of zygotically active genes. We compared the mRNA levels of 1,158 zygotic genes at 0–1 h with that observed at 2–3 h (Figure 3
The remaining two thirds of the 1,158 zygotic genes were present in unfertilized eggs (Table S6). Because the overall levels of theses mRNAs either did not change significantly or decreased between 0 h and 3 h, the dependence of cycle 14 levels on zygotic transcription implies the specific degradation of maternal transcripts before that time. Thus, we conclude that an increase in gene expression over time is not a sufficient criterion to identify zygotic genes. To follow the stability of maternal transcripts (which is obscured by the presence of newly supplied zygotic transcripts in WT embryos), we compared mRNA levels from early 0–1-h embryos (WT) with mRNA levels from embryos missing each chromosome, hand-selected from the same stock during cycle 14. The initial analysis was restricted to genes on the left arm of the second chromosome (Figure 3
Zygotic Transcription Generates Restricted Pattern of Gene Expression One third of the zygotic transcripts we have identified are not expressed maternally and can be considered purely zygotic genes. These genes are enriched for transcription factors (“transcription factor activity” Gene Ontology (GO) category, p < 10−9). This may reflect the necessity of timing the activity of genes regulating the establishment of cell identity during differentiation. The remaining two thirds, those with maternal contribution, are not significantly enriched in any specific functional class. This raises the question as to why the embryo transcribes genes when the corresponding maternal transcripts are present. Two possible scenarios can be envisaged: (1) maternal transcripts must also be supplied by zygotic transcription, because they are degraded very quickly (i.e., they have short half-lives), and (2) zygotic transcription offers some advantages, such as precise spatial patterning, differential processing (e.g., splice variants), or intracellular localization. In the latter scenario, maternal mRNAs would be specifically degraded to ensure that zygotic transcripts are the only source of these genes at cycle 14. Using data downloaded from the BDGP in situ database, we asked whether the zygotic genes we have identified are expressed in specific patterns at cycle 14 (Figure 3 Down-Regulated Maternal Genes and Zygotic Genes Share Distinct Common Motifs We then asked whether the different categories defined above share common genomic regulatory elements, which could explain the behavior of an individual gene during the MZT. We first investigated whether down-regulated maternal genes have over-represented motifs in their 3′ UTRs. A total of 1,095 maternal genes with annotated 3′ UTRs decreased in levels significantly between 0–1 h and 2–3 h. As shown in Figure 3 We then investigated whether the zygotic transcripts share common DNA regulatory motifs in their upstream regions. We identified a highly over-represented 7-nucleotide–long sequence (CAGGTAG, which from now on we will refer to as the 7mer) and several of its variants within the 2 kilobase (kb) upstream regions of purely zygotic genes (Figure 3 CAGGTAG and the Activation of the Zygotic Genome The results described above are intriguing because the 7mer we found is present upstream of only a fraction of the zygotic genes at cycle 14. Although the major activation of the zygotic genome occurs at cycle 14, earlier reports indicated signs of zygotic transcription as early as cycle 10 when the embryonic DNA is still engaged in fast cycles of S-phases and mitoses without interphases [23]. We therefore asked whether the 7mer represents a general feature of genes expressed prior to cycle 14 and, in general, whether the zygotic genes we have identified are transcribed altogether during cycle 10 or whether different classes of transcripts respond differently to the embryonic cycles and DNA content. We compared the expression profile of unfertilized eggs, 0–1-h freshly fertilized eggs (pre-pole cell formation, cycles 1–9) and 1–2-h embryos (post-pole cell formation and pre-cellularization, cycles 10–13). No significant change in expression levels was observed between unfertilized eggs and the 0–1-h eggs, indicating that neither transcription nor degradation has occurred (Figure S2). Importantly, in these experiments, we analyzed unfertilized eggs that had been aged for 1 h at most. Therefore, our results do not contradict previous reports describing the degradation of a subset of maternal transcripts in unfertilized eggs [17,24] since, in those studies, unfertilized eggs were aged for longer periods of time, and degradation was observed after 2 h, peaking between 2 and 4 h. Between the 0–1-h to 1–2-h collections, a single group of 59 genes was significantly up-regulated (Figure 4
Biochemical Purification of Bicoid Stability Factor as the 7mer Binding Protein The identification of a single highly over-represented cis-element in the 5′ region of the early zygotic genes suggests the existence of a single trans-acting factor involved in timing the activation of the zygotic genome. If such a factor exists, it is most likely maternally provided and loaded into the egg during oogenesis. To identify this factor, we undertook a biochemical approach. We performed sequential DNA affinity chromatography (see Materials and Methods for details) using the 7mer or, as negative control, the upstream activation sequence (UAS) (the consensus binding site of the yeast trans-activator GAL4). The result of this experiment is shown in Figure 5
BSF has been previously identified as a Bicoid mRNA binding protein involved in regulating the stability of Bicoid transcripts during oogenesis [25]. Our data suggest an additional transcriptional function for BSF in the embryo, and indeed, the human homolog of BSF has been shown to function as a transcriptional regulator [26]. In order to address the specificity of the 7mer/BSF interaction, BSF was expressed in rabbit reticulocyte in the presence of 35S methionine, and the binding to the 7mer or to a mutated oligo (in which the two GG at position 3 and 4 were mutated to TT) was tested. In vitro–synthesized BSF bound directly and specifically to the 7mer, and only background signal was retained on the beads coupled to the mutated oligo (Figure 5 Next, we analyzed the subcellular distribution of BSF in the embryo using immunostaining and confocal microscopy imaging. BSF was localized to both the cytoplasm as well as the nuclei of the blastoderm epithelium (Figure 5 To test the function of BSF in the early embryo, it is necessary to remove the maternal contribution. (BSF transcripts are maternally provided and the protein is expressed during oogenesis [25].) To perform this experiment, we produced germline clones using a P element insertion that maps in the BSF open reading frame and is homozygous lethal. Flies containing such clones failed to lay eggs, and the ovaries were arrested at a very early stage of development, indicating that BSF is required also during oogenesis. This made it impossible to test the function of BSF in the early embryo. Therefore, we took an alternative approach with the aim to functionally characterize the activity of the 7mer. We considered two possible scenarios. One possibility is that the 7mer may have enhancer activity, sufficient to drive transcription on its own. Alternatively, it may play a permissive role by functioning in a combinatorial fashion with additional factors. To discriminate between these two possibilities, we set up conditions to measure gene expression using an assay based on the UAS/GAL4 system [27]. CAGGTAG Activates Transcription Prior to Cycle 14 We generated embryos expressing green fluorescent protein (GFP) under the control of the UAS–heat shock minimal promoter either with or without five copies of the 7mer, and followed GFP expression using video microscopy. GFP was not detected in embryos unless GAL4 was also provided. Strikingly, the presence of the 7mer led to a more than 4-fold increase in the expression of GFP compared to controls (transgene without the 7mer), as shown in Figure 6
Next, we asked how early this stimulatory activity could be detected. We analyzed GFP transcripts using fluorescent in situ hybridization (FISH). This technology allows the visualization of nascent transcripts as they arise from the site of transcription [28]. Because we crossed males carrying the GFP transgene to females providing GAL4, only one chromosome in the embryo is expected to transcribe GFP. In agreement with this prediction, we detected only one major transcription focus, appearing as an individual dot, per nucleus (Figure 6 Embryos were harvested either at the stage when the earliest GFP transcripts were expressed (cycle 10 to 13) or at cycle 14. Total RNA was extracted and subjected to reverse-transcription PCR (RT-PCR) (Figure 6
Discussion The switch from maternal to zygotic control of early embryonic development is characterized by a dramatic remodeling of the transcriptional complexity present in the oocyte. We have genetically identified the relative maternal and zygotic contribution for the expression of each individual gene during the D. melanogaster mid-blastula transition. The criterion we used to identify zygotically expressed genes is strictly based on the direct relationship between the DNA template and the corresponding transcript. The specific phenotype generated upon removal of each chromosomal arm allowed us to collect a synchronous population of embryos just at the stage when the first morphological signs of the zygotic genome become visible. The location of the majority of down-regulated genes to the chromosomal arm that was ablated provided an excellent control for the entire experimental procedure we have undertaken. In summary, our results indicate that zygotic transcription contributes to approximately 20% of the genes expressed at cycle 14, and as much as 30% of maternal transcripts become unstable during the mid-blastula transition. However, about a third of these transcripts are also supplied by zygotic transcription and, therefore, their expression levels at cycle 14 remain constant. Purely zygotic transcripts represent only a third of the total set of zygotically expressed genes. The remaining two thirds also had a maternal contribution and were present in unfertilized or 0–1-h eggs. The zygotic transcription of such maternally provided genes does not always result in an increase in the total amount of transcript, indicating specific degradation of the maternal counterpart. Thus, a change in gene expression over time is not a sufficient criterion to identify zygotically active genes, nor to measure the stability of maternal transcripts. These results have important implications for the definition of maternal and zygotic genes, and provide a genome-wide analysis, which will be instrumental for a molecular characterization of the MZT. Our analysis shows that purely zygotic transcripts are enriched in transcription factors. Providing these genes through zygotic transcription, which in turn is related to the number of nuclei, ensures that correct number of cells is assigned to a specific fate and, ultimately, the establishment of the correct body proportion. The execution of a specific differentiation program represents a more complex problem, in that it involves the adjustment of the expression of genes involved in basic cell function. Therefore, these genes must be expressed during oogenesis, to support oocyte development, and their activity modulated through zygotic transcription. Our data argue that zygotic transcription allows a large fraction of ubiquitously expressed maternal mRNAs to be expressed again in localized patterns at the blastoderm stage. The generation of these patterns involves the degradation of the maternal transcript and the corresponding activation of zygotic transcription. This result is in agreement with previous studies on individual genes (e.g., the maternally provided Cdc25 phosphatase string and the maternal-zygotic transcription factor hunchback), which were reported to undergo a similar MZT [29,30]. Altogether our analysis is consistent with the proposal that zygotic transcription provides the spatial precision at which important regulatory genes must be expressed during the differentiation of the developing embryo. Therefore, our results can be used in combination with chromosomal deficiency screening to quickly identify gene function at the mid-blastula transition by reducing the number of candidate genes contained in each deficiency to zygotic-dependent expressed genes. We have used this approach to identify the bearded genes as the zygotic genes regulating Notch signaling during mesoectoderm specification [31]. In addition, our results show that zygotic transcription is required for the degradation of a distinct subset of maternal transcripts. Because these transcripts do not share any statistically enriched common regulatory sequence and because each chromosomal manipulation targeted distinct transcripts, we propose that multiple zygotic activities must be involved in this regulation. One possibility is that the zygotic expression of miRNAs might be part of this mechanism. For example, in zebrafish, mir-430 was shown to control the degradation of a pool of maternal transcripts [32]. Although we have not detected any significant over-representation of known miRNA target sites in our data, the involvement of miRNAs in specific pathways can be tested once zygotic control regions have been more closely defined. We also identified maternal mRNAs that are degraded and not replenished by zygotic transcription. A fraction of these genes share sequences within their 3′ UTR, which resemble the known target site for the Pumilio RNA-binding protein. We showed that a very large fraction of the Pumilio targets in the embryo are indeed degraded during the transition from maternal to zygotic stages. Pumilio was first identified as an inhibitor of translation controlling posterior fate by promoting deadenylation of hunchback mRNA [33,34]. Our results suggest that Pumilio might also promote degradation of mRNA targets as shown for the yeast homolog Puf3 [35]. The transition from a silent to a transcriptionally active genome is one of the most dramatic events in a developing embryo and is subject to regulation at multiple steps. We have identified the CAGGTAG motif (and its variants) as an important player in this transition. We identified the BSF as the factor binding to this motif in the early embryo. BSF has been previously identified as a protein binding to the 3′ UTR of Bicoid mRNA and involved in regulating Bicoid transcript stability during oogenesis [25]. However, the precise biochemical function of BSF is unknown. Mutation of this gene causes lethality, and induction of homozygous germline clones arrests oogenesis (see Results). Thus, BSF must have additional function other than the regulation of Bicoid transcripts because Bicoid itself is not required for oogenesis, and zygotic mutants are viable. Interestingly, the human ortholog of BSF, the leucine-rich protein LRP130, has been shown to bind to a cis-regulatory sequence in the 5′ proximal region of the MDR1 gene and to act as a transcriptional regulator [26,36]. Although we could not genetically test the function of BSF, our analysis suggests that BSF is not able to drive transcription on its own, but must act in a combinatorial fashion. Indeed, we found that CAGGTAG and its variants are particularly abundant in enhancer sequences bound by Dorsal and Bicoid (Table S9). These transcription factors activate the expression of their target genes in a concentration-dependent manner and define distinct developmental units along the dorsal-ventral (D-V) and anterior-posterior (A-P) axes [37,38]. Interestingly, only a subset of the known targets for these transcription factors have this element, even within the same spatial unit. For example, in the D-V patterning system controlled by the Dorsal gradient, CAGGTAG is found in Snail and Tom, but not Neuralized. Both Snail and Tom are expressed prior to Neuralized (Snail and Tom are among the 59 genes induced during cycle 10–11) and must act before Neuralized to precisely position Notch signaling at the mesoderm–mesoectoderm boundary [31]. The inability of CAGGTAG to drive transcription on its own makes it an ideal timer, which links spatial gradient with temporal regulation (see model, Figure 7 In conclusion, the experiments described in this work will be instrumental for studying the activation of the zygotic genome in other animals and for guiding embryonic stem cell differentiation. In the mouse, zygotic transcription begins by the two-cell stage, and a large number of maternal mRNAs persist beyond this stage [4]. The contribution of zygotic transcription to the expression of these mRNAs is still unknown. Further, the activation of the mouse genome is characterized by discrete wave-like patterns of gene expression. Similarly, the activation of the Drosophila genome starts with a battery of 59 transcripts induced from cycles 10–11 to cycle 14. Interestingly, 70% of these genes do not contain introns, and they all encode small proteins. This result is in agreement with two previous studies showing that genes transcribed early in development tend to be unusually short [39] and that the presence of a long intron (19 kb) limits the expression of the knirps-related gene (knrl) early during Drosophila development [40]. The use of intronless genes might reflect the necessity of expressing regulatory genes requiring a minimal response time. Intriguingly, many short genes in the human genome have been implicated in anti-sense–mediated gene regulation [41]. In the Drosophila embryo, the expression of intronless genes occurs when the nuclei are still engaged in rapid phases of DNA duplication and mitoses. Because the nuclear membrane is required for the assembly of the splicing machinery, the selection of intronless genes might ensure the production of functional transcripts in concomitance with nuclear divisions. Materials and Methods Genetics and flies stocks. WT flies were Oregon-R; all stocks were maintained by standard methods at 18 °C, unless otherwise specified. Transgenic embryos over-expressing GFP were generated using P element–mediated germline transformation using w1118 as the recipient host. GFP was ectopically expressed using the 7merUAS-GFP line 4 (III) or UAS-GFP line 10 (II) and the matαTub-Gal4VP16 67C;15 driver. Embryos were collected at room temperature. The halo deficiency is Df(2L)dpp[s7-dp35] 21F1–3;22F1–2 and was balanced over CyO [13]. Compound chromosomes: embryos with no X chromosome were obtained by crossing attached-X/Y females to X/Y males. The stock used was C(1) DX, y f [7]. The compound II chromosomes RM(2L); RM(2R) = C(2)v, in which the two left arms or the two right arms segregate together, were used to generate 2L− and 2R− embryos [8]. The compound II C(2) EN and compound III C(3) EN st1, cu1, es, stocks (Bloomington 2974 and 1117) were used to generate embryos deficient for the entire second and third chromosome, respectively. The BSF P element insertion used for the germline clone experiments was obtained from the Szged stock center: FRT-l(2)SH1181. This P element insertion has been mapped to the BSF cDNA and is homozygous lethal. Moreover, it failed to complement a deficiency covering the BSF genomic locus Df(2L)M36F-S5. Microarray. Embryos were collected on apple juice-agar plates, visually staged under a compound microscope, dechorionated for 2 min in 5.25% sodium hypochlorite (Austin's bleach), washed in water, and then frozen in 1 ml of heptane (Sigma, http://www.sigmaaldrich.com) using a dry ice/ethanol chamber. Total RNA was extracted with TRIzol (Invitrogen, http://www.invitrogen.com), and 10 mg of RNA (approximately 100 embryos) was used to synthesize complementary RNA (cRNA) according to the Affymetrix protocol. Each array (standard format: Drosophila genome 1, Affymetrix) was probed with 15 mg of biotinilated cRNA for 16 h in a 45 °C oven. Arrays were washed and stained using the GeneChip Fluidics Station (Affymetrix, http://www.affymetrix.com) according to the EukGE-WS2 protocol. Subsequently the arrays were scanned with an Argon-ion laser scanner (Affymetrix). Graphs were generated using the GeneSpring software (Silicon Genetics/Agilent, http://www.chem.agilent.com). CEL files were loaded in R (http://www.r-project.org), and analyzed using the Bioconductor package [42]. The analysis followed the “Golden Spike” methodology described in [43]. Briefly, Present, Marginal, or Absent flags were computed using the MAS approach, with default parameters. Within a group of replicates of the same condition, a probe set was identified as present if it had a Present flag (not Marginal) in more than 50% of the replicates. Intensity values were corrected using the MAS approach, and arrays were normalized with respect to each other at the probe level using a loess function. PM probe intensities were corrected for unspecific hybridization using the MM probes and the MAS approach. Expression summaries were generated using the MedianPolish method. A second loess correction was subsequently applied to the expression summaries. Two-tailed statistical tests were performed on the replicates using the regularized t-test approach implemented in CyberT [44], with normalization constant set to five times the minimum number of replicates among the two populations analyzed, and the window size set to 101. Further set operations (unions and intersections) were performed at the probe set level, using custom R functions. Motif finding. Probe sets from the DrosGenome1 Affymetrix platform were matched to the latest version of the D. melanogaster cDNAs downloaded from ENSEMBL [45], as of August 2005 (BDGP4). Briefly, each probe was matched to the cDNA set using BLAST, with seed length 11, and e-value threshold 1e-5. Only probes with 100% identity to their match were considered. A probe set was considered to match a transcript if at least ten (out of 14) of its probes matched the transcript. Transcript identifiers were collapsed into their corresponding gene identifier. Two-kilobase upstream regions (up to the TSS when available, or to the ATG codon otherwise) and 3′ UTRs were downloaded from ENSEMBL, also as of August 2005. Only the longest 3′ UTR for a same gene was retained. Motif finding within a set of genes of interest was performed using an exhaustive k-mer enumeration and over-representation approach. Briefly, each 7mer was considered in turn (6-, 8-, 9- and gapped k-mers were also examined, but yielded negative or similar results). The set of genes of interest (e.g., early zygotic genes) that have at least one copy of the 7mer was determined, with size denoted as s1. The set of all Drosophila genes that have at least one copy of the same 7mer, in their upstream (or 3′ UTR) region was then determined, with size denoted as s2. The size of the overlap between the two sets was then calculated, and denoted as i. A p-value of the size of overlap being greater than i (representing the over-representation of the k-mer within s1) was calculated using the cumulative hypergeometric distribution. All 7mers were sorted based on their p-value, corrected for multiple testing using the Bonferroni correction. Only 7mers with corrected p-values lower than 0.05 were considered significant and used for further analysis. Motifs derived from 3′ UTRs were systematically compared to the seed regions within the sequences of the 78 known Drosophila miRNAs, downloaded in August 2005 from the miRNA registry [46]. Purification of BSF as the 7mer interacting protein. The 0–3-h. embryos were harvested, dechorionated for 2 min, washed in phosphate buffer saline (PBS) 0.1% Triton X-100, and frozen at −80 °C. Forty grams of packed embryos were diluted in 50 ml of Lysis buffer (25 mM Hepes [pH7.6]; 100 mM KCl; 12.5 mM MgCl2; 1 mM DTT; 10% glycerol; 500 μg of Poly DI-DC (Sigma), 1X Protease Inhibitor cocktail (P8340; Sigma) and homogenized in a Dounce tissue grinder at 4 °C. Total lysate was spun down for 5 min at 1,000 rpm in order to pellet the nuclei. Total membranes were spun down by ultracentrifugation in a 70 Ti rotor (Beckman, http://www.bioscience.com) at 40,000 rpm for 1 h at 4 °C. The supernatant from this centrifugation step was incubated for 5 h at 4 °C with 500 μl of immobilized streptavidin agarose beads (Pierce 20347; http://www.piercenet.com) coupled to 1 mg of double-stranded UAS oligo (51 bases long, three tandem copies of the GAL4 binding site) biotinylated at the 5′ end of the upper strand with a BioTEG (5′-BioTEGCGGAGTACTGTCCTCCGCGGAGTACTGTCCTCCGCGGAGTACTGTCCTCCG) and equilibrated in 100 mM KCl; 25 mM Hepes (pH 7.4). The flow true from this purification step was then loaded onto either 500 μl of beads containing the 7mer sequence (49 bases long, seven copies of the CAGGTAG repeat; (CAGGTAGCAGGTAGCAGGTAGCAGGTAG CAGGTAGCAGGTAGCAGGTAG) or onto 500 μl of UAS oligo beads prepared as described above and incubated for an additional 4 h at 4 °C. Columns were washed with 20 ml of wash buffer (100 mM KCl, 25 mM Hepes [pH 7.4]). Bound proteins were eluted in three fractions containing 5 mM EDTA, 50 mM Hepes (pH 7.4), 1 mM DTT and increasing concentration of KCl: first, 500 mM KCl; second, 1 M KCl, and third, 2 M KCl. Each elution step was performed by incubating the beads for 10 min in a total volume of 500 μl at room temperature. Each eluted fraction was concentrated and desalted on a centrifugal filter 3-kDa cut-off (Millipore CAT NO: 42403; http://www.millipore.com) and loaded on SDS-Page. The bound protein was cut and sequenced according to standard mass spectroscopy procedure. In vitro binding of BSF to the 7mer sequence. BSF cDNA was in vitro transcribed and translated in the presence of 35S methionine using the T7-TnT Quick-coupled transcription/translation system (Promega CAT NO: TM045; http://www.promega.com). We incubalted 60 μl of radio-labeled BSF for 3 h at 4 °C with 50 μl of beads containing the 7mer sequence or a mutated sequence (CATTTAG) prepared as described above, in a total volume of 500-μl buffer containing 25 mM Hepes (pH 7.4), 100 mM KCl, 12.5 mM MgCl; 1mM DTT 1-mg/ml BSA, and 2.5-mg poly dI-dC. After four washes in 1 ml of buffer containing 25 mM Hepes (pH 7.4), 100 mM KCl, and 1 mM DTT, bound proteins were eluted in 80 μl of 1.5 M NaCl, 50 mM Hepes (pH7.4), 5 mM EDTA, and 1 mM DTT. Then 30 μl of the eluted proteins were loaded on SDS-page and processed for autoradiography. CAGGTAG analysis. All variants of the CAGGTAG motif with a significant p-value were retained, and aligned manually. All occurrences of these variants within the 59 early genes were determined, along with their position with respect to the TSS; overlapping occurrences were removed. The remaining occurrences were used to form a weight matrix, whose motif logo was drawn using WebLogo [47]. All Drosophila enhancers in the Redfly database [48] were downloaded, as of March 2006. All enhancers were searched for the above variants of CAGGTAG, but only those that had at least two copies were retained. The density of CAGGTAG variants per kilobase was calculated for all retained enhancers, and enhancers were sorted according to this density. In situ database analysis. All available in situ data and corresponding annotation keywords were downloaded from the BDGP in situ database [49], as of August 2005. Only genes with detectable expression at stages 4–6 were retained for further analysis, resulting in a set of 1,227 genes. Based on the annotated keywords, gene expression at each stage was classified as uniformly expressed, patterned, or not detected. Cloning and RT-PCR quantification. Two complementary oligos each containing five copies of the CAGGTAG repeats flanked by a SphI restriction site at both the 5′ and 3′ extremities were in vitro synthesized, annealed, cut with SphI, and cloned into the SphI site of the pUasT-EGFP (1075) destination vector (Gateway; Invitrogen). Recombinant plasmids were identified using PCR and sequencing for correct orientation. For the quantification of GFP transcripts, 80 embryos were visually staged under a regular dissecting microscope, hand selected, and total RNA extracted using Trizol (Sigma). For each time point, 80 ng of total RNA was used in a one-step RT-PCR reaction (Invitrogen Superscript One-step RT-PCR). Twenty-five cycles of amplification at TM 55 °C ensured a linear range of amplification. The primers used were: GFP-F: ACGTAAACGGCCACAAGTTC; GFP-R: TGCTCAGGTAGTGGTTGTCG; Snail-F: CGGAACCGAAACGTGACTAT; Snail-R: GCGGTAGTTTTTGGCATGAT. Amplified reactions were loaded on a 1.2% agarose gel, stained with ethidium bromide, and quantified using a gel documentation system equipped with a CCD camera (FluorChem; Alpha Innotech, http://www.alphainnotech.com). Immunostaining. Embryos were dechorionated for 2 min in bleach and fixed in 4% paraformaldehyde (Electron Microscopy Science, http://www.emsdiasum.com/microscopy/)-heptane for 20 min. Embryos were blocked in 10% bovine serum albumin (BSA) in PBS, 0.1% Triton-X-100 (Sigma) for 1 h. Primary antibodies were incubated in PBS containing 5% BSA and 0.1% Tween-20 for 12 h at 4 °C. Embryos were washed five times in PBS, 0.1% Triton-X-100, and incubated with secondary antibodies for 2 h at room temperature in PBS, 5% BSA, 0.1% Tween-20. After five washes in PBS, stained embryos were mounted in Aquapolymount (Polyscience, http://www.polyscience.com). Antibodies: mouse anti-Armadillo (1:50); rabbit anti-myosin-2 (1:500). Secondary antibodies were Alexa-488 conjugated (1:500; Molecular Probes). For the detection of BSF, embryos were heat fixed and the goat anti-BSF antibody (P.M. Macdonald) was used at 1:500 dilution as described in [25]. FISH and image analysis. FITC-UTP–labeled RNA antisense probes against GFP were generated by cutting the pBlue script II EGFP(N) plasmids with KpnI and transcribing with the T7 polymerase. Embryos were dechorionated for 2 min in bleach and fixed in 4% paraformaldehyde (Electron Microscopy Science)-heptane for 20 min. Hybridization was performed in 50% formamide (Roche, http://www.roche.com), 5× SSC (Sigma), 1× Denharts (Sigma), 1% (w/v) blocking agent (Roche), 10-mg/ml yeast tRNA (Sigma), 0.1% Triton X-100 (Sigma), 0.1% CHAPS (Sigma) for 16 h at 56 °C. Thereafter, embryos were blocked in 2× Western blocking reagent (Roche), PBS, 0.1% Triton-X-100 (Sigma) for 1 h at room temperature and incubated with mouse anti-FITC (Roche) 1:400 incubated in blocking buffer for 3 h. Embryos were washed five times in PBS, 0.1% Triton-X-100, and incubated with anti-mouse Alexa488-conjugated secondary antibodies (Molecular Probes) used at 1:500 dilution for 1.5 h at room temperature in blocking buffer. After five washes, nuclei were stained using Toto-3 dye (Molecular Probes), incubated in 70% glycerol for 30 min, and mounted in Aquapolymount (Polyscience). Images were acquired with a PerkinElmer spinning disk confocal microscope equipped with a 40× (numerical aperture [na] 1.3) oil immersion objective (Nikon, http://www.nikon.com) using the Ultra VIEW imaging system (PerkinElmer, http://www.perkinelmer.com). Serial sections were collected, and the number and size of nuclear dots was quantified as follows. Image analysis was performed using MATLAB v7 and the Image Processing Toolkit (http://www.mathworks.com). Pixel intensities were first linearly stretched using the imadjust and stretchlim functions. Whole-embryo boundaries were located within the images using a thresholding of 0.20, a morphological opening with disk of radius 1 (pixel) for removal of small artifacts, a filling of type “hole” with radius 4, a morphological opening with disk of radius 20 for removing larger artifacts, followed by a morphological closing with disk of radius 1 for obtaining sharper boundaries. The resulting single object (representing the embryo) was used as a mask for further analysis. Intensities within the masks were then thresholded using a 0.99 cut-off. A morphological opening operation was used to remove small artifacts, using a disk of radius 1. The remaining objects (spots) were extracted from the image using the bwlabel function, and their number and area calculated using the regionprops function. For the GFP quantification, masks for each of the ten WT and nine 7mer embryos within the time course were drawn using Photoshop (Adobe Systems, http://www.adobe.com), from the first frame in the movie. These masks were subsequently used to study only the regions of interests (single embryos) in later frames. For each frame in the time course, the median pixel intensity with each embryo boundary was calculated. Average median intensities and corresponding standard deviations across the ten WT and nine 7mer embryos were finally calculated. Figure S1: FISH of GFP Transcripts during Cycle 11 to 14 Embryos were fixed and processed for FISH analysis. Stained embryos were imaged using confocal microscopy. Each panel corresponds to a stack of ten sections (0.5 μm/section). (A) to (D) correspond to embryos in cycles 11, 12, 13, and 14, respectively, expressing GFP under the 7mer sequence. (E) to (H) correspond to embryos in cycles 11, 12, 13, and 14, respectively, expressing GFP without the 7mer sequence. (2.1 MB JPG) Click here for additional data file.(2.1M, jpg) Figure S2: Microarray Measurements Comparing Unfertilized Eggs and 0–1-h Embryos Unfertilized eggs and 0–1-h embryos (prior to pole cell formation) were collected and their expression profile analyzed using microarrays. The majority of transcripts were present at similar levels in both collections. None of the changes were statistically significant, indicating the lack of both transcription and degradation. (621 KB JPG) Click here for additional data file.(622K, jpg) Table S1: List of Zygotic Genes: Primary List of mRNAs that were down-regulated at least 3-fold compared to similarly staged WT embryos in cycle 14, upon ablation of each chromosome, and that were located on the chromosome that was removed. These are the primary zygotic genes and include both purely zygotic as well as maternal+zygotic transcripts. The difference in expression level indicates the relative maternal and zygotic contribution to the expression level at cycle 14. Table key: “affy_probe_set_id” is the Affimetrix probe identifier; “fbgn for the probe set” corresponds to the fbgn number provided by Affymetrix; the “CGid” was determined using the mapping to the Drosophila genome I; “Chr. Location” indicates the chromosomal location where the down-regulated genes were located; fold-change refers to the fold change of down-regulated genes in mutant embryos compared to WT embryos in cycle14; the p-value for all measurements was less than 0.001. (86 KB PDF) Click here for additional data file.(87K, pdf) Table S2: List of Secondary Targets: Zygotic List of mRNAs that were down-regulated or up-regulated at least 3-fold, compared to similarly staged WT embryos in cycle 14, upon ablation of each chromosomes, and that, if down-regulated, were not located on the chromosome that was removed. However, these transcripts were identified as primary zygotic transcripts when the chromosome harboring them was removed. These are zygotic transcripts whose expression is controlled by other zygotic genes. Table key: “affy_probe_set_id” is the Affymetrix probe identifier; “fbgn for the probe set” corresponds to the fbgn number provided by Affymetrix; the “CGid” was determined using the mapping to the Drosophila genome I; “Chr. Location” indicates the chromosomal location where the down-regulated genes were located; fold-change refers to the fold change of down-regulated genes in mutant embryos compared to WT embryos in cycle14; the p-value for all measurements was less than 0.001. (31 KB PDF) Click here for additional data file.(31K, pdf) Table S3: List of Secondary Targets: Non-zygotic. List of mRNAs that were down-regulated or up-regulated at least 3-fold, compared to similarly staged WT embryos in cycle 14, upon ablation of each chromosome, and that were not identified as primary zygotic transcripts when the chromosome harboring them was removed. Therefore, these are maternal transcripts whose expression or stability is controlled by other zygotic genes. Table key: “affy_probe_set_id” is the Affymetrix probe identifier; “fbgn for the probe set” corresponds to the fbgn number provided by Affymetrix; the “CGid” was determined using the mapping to the Drosophila genome I; “Chr. Location” indicates the chromosomal location where the down-regulated genes were located; fold-change refers to the fold change of down-regulated or up-regulated genes in mutant embryos compared to WT embryos in cycle 14; the p-value for all measurements was less than 0.001. (31 KB PDF) Click here for additional data file.(31K, pdf) Table S4: List of Purely Zygotic Genes (Identified Using Chromosome Deletion + Time Course) List of mRNAs that were not expressed at 0–1 h, were down-regulated at least 3-fold compared to similarly staged WT embryos in cycle 14, upon ablation of each chromosome, and that were located on the chromosome that was removed. Therefore, these are purely zygotic transcripts and represent a subgroup of Table S1. This last table includes both purely zygotic as well as maternal+zygotic. Table key: “affy_probe_set_id” is the Affymetrix probe identifier; “fbgn for the probe set” corresponds to the fbgn number provided by Affymetrix; the “CGid” was determined using the mapping to the Drosophila genome I; “Chr. Location” indicates the chromosomal location where the down-regulated genes were located; fold-change refers to the fold change of down-regulated genes in mutant embryos compared to WT embryos in cycle 14; the p-value for all measurements was less than 0.001. (41 KB PDF) Click here for additional data file.(41K, pdf) Table S5: List of Purely Zygotic Genes (Identified Using Only Time Course) List of mRNAs which were not expressed at 0–1 h, and were expressed at 2–3 h. These are purely zygotic transcripts identified using solely the time course measurement. Note that this list contains 300 out of the 334 transcripts identified in Table S4 (see text for more details). Table key: “affy_probe_set_id” is the Affymetrix probe identifier; “fbgn for the probe set” corresponds to the fbgn number provided by Affymetrix; the “CGid” was determined using the mapping to the Drosophila genome I; “Chr. Location” indicates the chromosomal location where the up-regulated genes were located; fold-change refers to the fold change of up-regulated genes in 2–3-h embryos compared to 0–1-h embryos; the p-value for all measurements was less than 0.001. (60 KB PDF) Click here for additional data file.(61K, pdf) Table S6: List of Maternal-Zygotic Transcripts List of mRNAs that were down-regulated at least 3-fold, compared to similarly staged WT embryos in cycle 14, upon ablation of each chromosome, and that were expressed also during maternal stages (0–1-h collection). These are zygotic transcripts, which also had maternal contribution. Table key: “affy_probe_set_id” is the Affymetrix probe identifier; “fbgn for the probe set” corresponds to the fbgn number provided by Affymetrix; the “CGid” was determined using the mapping to the Drosophila genome I; “Chr. Location” indicates the chromosomal location where the down-regulated genes were located; fold-change refers to the fold change of down-regulated genes compared to WT embryos in cycle 14; the p-value for all measurements was less than 0.001. (70 KB DOC) Click here for additional data file.(71K, pdf) Table S7: List of Zygotic Transcripts Down-Regulated from 0–1 to 2–3 h List of mRNAs that were down-regulated at least 3-fold during the maternal-to-zygotic transition (from 0–1 h to 2–3 h) and that were down-regulated at least 3-fold upon ablation of the chromosomes on which they mapped compared to similarly staged cycle 14 WT embryos. Table key: “affy_probe_set_id” is the Affymetrix probe identifier; “fbgn for the probe set” corresponds to the fbgn number provided by Affymetrix; the “CGid” was determined using the mapping to the Drosophila genome I; “Chr. Location” indicates the chromosomal location where the down-regulated genes were located; fold-change refers to the fold change of down-regulated genes compared to WT embryos in cycle 14; the p-value for all measurements was less than 0.001. (59 KB PDF) Click here for additional data file.(60K, pdf) Table S8: List of Early Zygotic Genes (1–2 h) List of mRNAs that were not expressed at 0–1 h, and were up-regulated at 1–2 h. These are the earliest 59 zygotic expressed genes. Table key: “affy_probe_set_id” is the Affymetrix probe identifier; “fbgn for the probe set” corresponds to the fbgn number provided by Affymetrix; the “CGid” was determined using the mapping to the Drosophila genome I; “Chr. Location” indicates the chromosomal location where the up-regulated genes were located; fold-change refers to the fold change of up-regulated genes in 1–2-h embryos compared to 0–1 h embryos; the p-value for all measurements was less than 0.001. (22 KB PDF) Click here for additional data file.(22K, pdf) Table S9: CAGGTAG (and Variants) Occurrences within Experimentally Verified cis-Regulatory Modules Densities of CAGGTAG (and variants) occurrences within experimentally verified cis-regulatory modules (CRMs), from the RedFly database. CRMs with the highest density of CAGGTAG/variants are bound by Bcd or Dl. Table key: “# of CAGGTAG/kb” indicates the density of CAGGTAG(+variants)/kb, “CRM length (bp)” is the length of cis-regulatory modules in base pairs; “# of CAGGTAG” is the counted number of CAGGTAG(+variants) in the CRM; “CRM name (RedFly)” indicates the nomenclature of each specific CRM according to the Regulatory Element Database for Drosophila (REDfly) (32 KB PDF) Click here for additional data file.(32K, pdf) Acknowledgments We thank all members of the Wieschaus and Tavazoie laboratories for helpful discussions. We thank N. Denef, J. Goodliffe, O. Grimm, J. Li, A. Martin, D. Robson, and T. Schupbach for critical reading of the manuscript. We thank Donna Storton (microarray) and Joe Goodhouse (confocal microscopy) for their advice and assistance. We thank Paul M. Macdonald for providing anti-BSF antibodies, BSF cDNA, and fly stocks. We thank the Bloomington Drosophila Stock Center for providing fly stocks. SDR was supported by a Human Frontier Science Program long-term fellowship. Abbreviations
Footnotes Author contributions. SDR and EFW conceived and designed the experiments. SDR performed the experiments. SDR. OE, ST, and EFW analyzed the data. SDR, OE, and EFW contributed reagents/materials/analysis tools. SDR and OE wrote the paper. Funding. This work was supported by the Howard Hughes Medical Institute and by National Institute of Child Health and Human Development grant 5R37HD15587 to EFW, and a National Human Genome Research Institute grant 5R01 hG3219–3 to ST. Competing interests. The authors have declared that no competing interests exist. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Genetics. 1996 Jan; 142(1):5-10.
[Genetics. 1996]Cell. 1982 Oct; 30(3):687-96.
[Cell. 1982]Dev Cell. 2004 Jan; 6(1):117-31.
[Dev Cell. 2004]Development. 2003 Mar; 130(5):889-900.
[Development. 2003]Development. 1988 Nov; 104(3):483-93.
[Development. 1988]Development. 1988 Nov; 104(3):495-509.
[Development. 1988]Genetics. 1996 Jan; 142(1):5-10.
[Genetics. 1996]Cell. 1982 Oct; 30(3):687-96.
[Cell. 1982]Nature. 2000 Feb 3; 403(6769):501-2.
[Nature. 2000]Science. 2002 Sep 27; 297(5590):2270-5.
[Science. 2002]Curr Biol. 2003 Sep 30; 13(19):1660-8.
[Curr Biol. 2003]J Cell Biol. 2000 Jul 24; 150(2):391-401.
[J Cell Biol. 2000]Curr Biol. 2003 Sep 30; 13(19):1660-8.
[Curr Biol. 2003]Cell. 1993 Oct 22; 75(2):373-85.
[Cell. 1993]Genes Dev. 1996 Aug 1; 10(15):1966-77.
[Genes Dev. 1996]Dev Cell. 2007 Jan; 12(1):143-55.
[Dev Cell. 2007]Proc Natl Acad Sci U S A. 2006 Mar 21; 103(12):4487-92.
[Proc Natl Acad Sci U S A. 2006]Cell. 1986 Aug 29; 46(5):659-67.
[Cell. 1986]Cell. 2005 Mar 11; 120(5):623-34.
[Cell. 2005]Development. 1998 Aug; 125(16):3259-68.
[Development. 1998]Development. 2006 May; 133(10):1967-77.
[Development. 2006]Cell. 1986 Mar 28; 44(6):871-7.
[Cell. 1986]Dev Cell. 2007 Jan; 12(1):143-55.
[Dev Cell. 2007]Genetics. 2003 Jul; 164(3):989-1001.
[Genetics. 2003]Mol Cell Biol. 2001 May; 21(10):3462-71.
[Mol Cell Biol. 2001]Nucleic Acids Res. 2004; 32(13):3864-76.
[Nucleic Acids Res. 2004]Mol Cell Biol. 2001 May; 21(10):3462-71.
[Mol Cell Biol. 2001]Development. 1993 Jun; 118(2):401-15.
[Development. 1993]Science. 2004 Aug 6; 305(5685):846.
[Science. 2004]Cell. 1989 Apr 7; 57(1):177-87.
[Cell. 1989]Cell. 1997 Feb 7; 88(3):309-14.
[Cell. 1997]Dev Cell. 2006 Feb; 10(2):257-64.
[Dev Cell. 2006]Science. 2006 Apr 7; 312(5770):75-9.
[Science. 2006]Genes Dev. 1999 Oct 15; 13(20):2704-12.
[Genes Dev. 1999]Mol Cell Biol. 2001 May; 21(10):3462-71.
[Mol Cell Biol. 2001]Nucleic Acids Res. 2004; 32(13):3864-76.
[Nucleic Acids Res. 2004]Genes Dev. 2006 Nov 1; 20(21):2996-3009.
[Genes Dev. 2006]Cell. 2002 Nov 27; 111(5):687-701.
[Cell. 2002]Cell. 1988 Jul 1; 54(1):95-104.
[Cell. 1988]Dev Cell. 2006 Feb; 10(2):257-64.
[Dev Cell. 2006]Dev Cell. 2004 Jan; 6(1):117-31.
[Dev Cell. 2004]Cell. 1976 Jun; 8(2):305-19.
[Cell. 1976]Nature. 1992 Sep 10; 359(6391):156-9.
[Nature. 1992]Trends Genet. 2005 Apr; 21(4):203-7.
[Trends Genet. 2005]Curr Biol. 2003 Sep 30; 13(19):1660-8.
[Curr Biol. 2003]Development. 1988 Nov; 104(3):483-93.
[Development. 1988]Development. 1988 Nov; 104(3):495-509.
[Development. 1988]Genome Biol. 2004; 5(10):R80.
[Genome Biol. 2004]Genome Biol. 2005; 6(2):R16.
[Genome Biol. 2005]Bioinformatics. 2001 Jun; 17(6):509-19.
[Bioinformatics. 2001]Nucleic Acids Res. 2007 Jan; 35(Database issue):D610-7.
[Nucleic Acids Res. 2007]Nucleic Acids Res. 2006 Jan 1; 34(Database issue):D140-4.
[Nucleic Acids Res. 2006]Genome Res. 2004 Jun; 14(6):1188-90.
[Genome Res. 2004]Bioinformatics. 2006 Feb 1; 22(3):381-3.
[Bioinformatics. 2006]Genome Biol. 2002; 3(12):RESEARCH0088.
[Genome Biol. 2002]Mol Cell Biol. 2001 May; 21(10):3462-71.
[Mol Cell Biol. 2001]